The China Securities Regulatory Commission has given informal guidance to investment banks and companies that prospective robotics listings should be able to demonstrate recurring revenue, meaningful progress toward reducing losses or significant technological innovation, according to reporting from The Information cited by Reuters. The guidance has not been formally published by the regulator.
The move follows the highly volatile public-market debut of Unitree Robotics.
Unitree’s shares initially surged roughly fivefold following its Shanghai listing before subsequently falling around 45% from their peak. The rapid rise and correction have reportedly increased regulatory concerns around speculation in China’s rapidly expanding humanoid robotics sector.
The development comes as a growing number of Chinese robotics companies explore public listings while the industry’s commercial fundamentals remain relatively early.
The reported requirements are notable because they put greater emphasis on demonstrating actual commercialization rather than relying primarily on expectations around the future size of the humanoid market.
China has become one of the world’s most active markets for humanoid robotics, supported by a large domestic component supply chain, government programs and rapidly expanding manufacturing capacity. But many companies remain in the transition between research, pilot deployments and repeatable commercial revenue.
If implemented broadly, the tougher scrutiny could affect the timing and valuations of upcoming Chinese robotics listings, particularly for younger companies still operating at significant losses.
